The present authors previously compared a cohort of patients with early‐stage breast cancer treated at the Odense University Hospital, Denmark, with matched controls 14, and showed that serum levels of free IGF‐I and free IGF‐II were elevated, whereas the respective total IGF levels were lower in patients with cancer than in controls. The gene discussed is IGF2; the disease is cancer.